Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RPG Life Sciences's Other Operating Expense for the
three
months ended in Jun. 2026 was ₹902 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹3,414 Mil.
RPG Life Sciences's quarterly Other Operating Expense
increased
from Dec. 2025 (₹808 Mil) to Mar. 2026 (₹892 Mil) and
increased
from Mar. 2026 (₹892 Mil) to Jun. 2026 (₹902 Mil).
RPG Life Sciences's annual Other Operating Expense
increased
from Mar. 2024 (₹2,103 Mil) to Mar. 2025 (₹2,103 Mil) and
increased
from Mar. 2025 (₹2,103 Mil) to Mar. 2026 (₹2,382 Mil).
RPG Life Sciences Other Operating Expense Related Terms
RPG Life Sciences Other Operating Expense Historical Data
* Premium members only.
The historical data trend for RPG Life Sciences's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,414 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹3,414 Mil mean?
RPG Life Sciences (NSE:RPGLIFE) has a Other Operating Expense of ₹3,414 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on RPG Life Sciences and its competitors.
Is RPG Life Sciences' Other Operating Expense too high?
RPG Life Sciences' current Other Operating Expense is ₹3,414 Mil. Overall, RPG Life Sciences has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Other Operating Expense compare to ZTS?
RPG Life Sciences' Other Operating Expense of ₹3,414 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on RPG Life Sciences and its competitors. RPG Life Sciences's current Other Operating Expense is ₹3,414 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,463.17, compared to a current price of ₹2,633.40 — trading 6.9% above its estimated fair value. The current Other Operating Expense is ₹3,414 Mil. RPG Life Sciences' overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Other Operating Expense is ₹3,414 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, RPG Life Sciences stock appears to be overvalued.
The current stock price of ₹2,633.40 is trading 6.9% above its estimated GF Value™ of ₹2,463.17.
GuruFocus considers RPG Life Sciences to be Fairly Valued.
Key valuation signals for NSE:RPGLIFE:
Other Operating Expense: ₹3,414 Mil
GF Value™: ₹2,463.17 vs. price of ₹2,633.40 (6.9% above fair value)
No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
91GF Score
Get the complete analysis for NSE:RPGLIFE
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RPGLIFE has been successfully added to your 
